Skip to content

Clinical trials

Phase 1 Carcinoma, Medullary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Medullary Phase: Phase 1 Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20031
20042
20051
20081
20102
20122
20151
20161
20171
20182
20212
20231
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting4
Not yet recruiting2
Withdrawn2
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
European Organisation for Research and Treatment of Cancer - EORTC2
University Hospital, Basel, Switzerland2
University of Pennsylvania2
Boston Pharmaceuticals1
Case Comprehensive Cancer Center1
Duke University1
Exelixis1
First Affiliated Hospital of Fujian Medical University1
Jonsson Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Medullary28
Salivary Gland Neoplasms10
Carcinoma, Non-Small-Cell Lung9
Thyroid Neoplasms9
Breast Neoplasms8
Breast Neoplasms, Male7
Carcinoma, Hepatocellular7
Carcinoma, Renal Cell7
Colonic Neoplasms7
Head and Neck Neoplasms7

Trials

Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.